EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum β-hCG Combined with Traditional Tumor Markers Improves Detection Efficacy and Prognostic Prediction in Cholangiocarcinoma

Suppakrit Kongsintaweesuk iD, Thatsanapong Pongking iD, Keerapach Tunbenjasiri, Pakornkiat Tanasuka iD, Sittiruk Roytrakul iD, Sudarat Onsurathum, Chawalit Pairojkul, Kitti Intuyod, Vor Luvira, Somchai Pinlaor iD, David Blair iD, Porntip Pinlaor iD

International Journal of Molecular Sciences · 16.06.2026 · 27 (12) · 5438

DOI: 10.3390/ijms27125438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.06.2026. Verfasst von Suppakrit Kongsintaweesuk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Science Program, Graduate School, Khon Kaen University, Khon Kaen 40002, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Biomarkers, Tumor, Chorionic Gonadotropin, beta Subunit, Human, Bile Duct Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khon Kaen University, National Institute of Information and Communications Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) in Northeast Thailand is characterized by late diagnosis and poor prognosis, creating a critical need for effective early-detection biomarkers. This study utilized a multi-omics approach to identify novel diagnostic targets and improve CCA screening. Initial serum proteomic and transcriptomic analyses revealed significant upregulation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in CCA patients, correlating with advanced disease stages. Interaction network analysis subsequently identified its circulating ligand, beta-human chorionic gonadotropin (β-hCG), as a highly translatable clinical target. The protein expression of β-hCG was assessed via immunohistochemistry (IHC) in 100 tissue samples, and serum levels of β-hCG, alongside routine markers (CA19-9, AFP, and CEA), were quantified in a cohort of 405 individuals, including 153 CCA patients. IHC confirmed significantly higher β-hCG expression in tumor tissues compared to adjacent areas (p < 0.0001). Serum β-hCG levels were significantly elevated in CCA patients and correlated with tumor volume and reduced overall survival. Diagnostically, a combined multiparameter panel (β-hCG, carbohydrate antigen 19-9, carcinoembryonic antigen, and alpha-fetoprotein) yielded excellent accuracy in distinguishing CCA from healthy controls (AUC: 0.962) and hepatocellular carcinoma cases (AUC: 0.890). However, discriminatory efficiency was notably lower when differentiating CCA from benign biliary diseases (AUC: 0.680) and liver metastases (AUC: 0.705). In conclusion, activation of the LHCGR signaling axis is a novel pathophysiological feature in CCA. When integrated into a multi-marker blood panel, circulating β-hCG serves as a valuable complementary risk-stratification and prognostic tool, though further optimization is required to overcome limited specificity in the presence of confounding liver pathologies before routine clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBiomarkers, TumorChorionic Gonadotropin, beta Subunit, HumanBile Duct NeoplasmsHumansFemalePrognosisMaleMiddle AgedCarcinoembryonic AntigenAgedCA-19-9 Antigenalpha-FetoproteinsAdult

Stichwörter der Autor:innen

bile duct cancerbiomarkerliver cancer

Substanzen

Biomarkers, TumorChorionic Gonadotropin, beta Subunit, HumanCarcinoembryonic AntigenCA-19-9 Antigenalpha-Fetoproteins

Autor:innen und Institutionen

  • Biomedical Science Program, Graduate School, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani 12120, Thailand.
  • Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.

ORCID-Profile: Suppakrit Kongsintaweesuk, Thatsanapong Pongking, Pakornkiat Tanasuka, Sittiruk Roytrakul, Somchai Pinlaor, David Blair, Porntip Pinlaor

Förderung

  • Khon Kaen University
  • National Institute of Information and Communications Technology

Zitieren

APA

Kongsintaweesuk, S., Pongking, T., Tunbenjasiri, K., Tanasuka, P., Roytrakul, S., Onsurathum, S., Pairojkul, C., Intuyod, K., Luvira, V., Pinlaor, S., Blair, D., & Pinlaor, P. (2026). Serum β-hCG Combined with Traditional Tumor Markers Improves Detection Efficacy and Prognostic Prediction in Cholangiocarcinoma. International Journal of Molecular Sciences, 27(12), 5438. https://doi.org/10.3390/ijms27125438

Vancouver

Kongsintaweesuk S, Pongking T, Tunbenjasiri K, Tanasuka P, Roytrakul S, Onsurathum S, et al. Serum β-hCG Combined with Traditional Tumor Markers Improves Detection Efficacy and Prognostic Prediction in Cholangiocarcinoma. International Journal of Molecular Sciences. 2026;27(12):5438. doi:10.3390/ijms27125438

BibTeX
@article{Kongsintaweesuk2026,
  author = {Kongsintaweesuk, Suppakrit and Pongking, Thatsanapong and Tunbenjasiri, Keerapach and Tanasuka, Pakornkiat and Roytrakul, Sittiruk and Onsurathum, Sudarat and Pairojkul, Chawalit and Intuyod, Kitti and Luvira, Vor and Pinlaor, Somchai and Blair, David and Pinlaor, Porntip},
  title = {Serum β-hCG Combined with Traditional Tumor Markers Improves Detection Efficacy and Prognostic Prediction in Cholangiocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5438},
  doi = {10.3390/ijms27125438}
}
Kostenlos starten →